Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Reexamination Certificate
2005-05-16
2008-10-14
Andres, Janet L. (Department: 1625)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
C546S221000
Reexamination Certificate
active
07435746
ABSTRACT:
A compound comprisingor a pharmaceutically acceptable salt or a prodrug thereof is disclosed herein. Y and R are described in detail hereinA compound having an ω chain comprisingor a derivative thereof, or a pharmaceutically acceptable salt or a prodrug thereof, is disclosed. Derivatives, salts and prodrugs are identified and described in detail.Methods of treating certain conditions or diseases, and compositions and medicaments related thereto are also contemplated.
REFERENCES:
patent: 2003/0207925 (2003-11-01), Cameron et al.
patent: 2004/0142969 (2004-07-01), Elworthy
Kass et al., Arch Ophthalmol, 2002, 120, 701-713.
Dinh Danny T.
Old David W.
Allergan Inc.
Allergan, Inc.
Andres Janet L.
Gallis David E
Johnson Brent A.
LandOfFree
5-thiopiperdinyl prostaglandin E analogs does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with 5-thiopiperdinyl prostaglandin E analogs, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and 5-thiopiperdinyl prostaglandin E analogs will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3988956